fda compounding glp-1 enforcement news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Congress Introduces SAFE Drugs Act
Description
PenCycle is the new way to recycle your used Saxenda and Wegovy pens

Usually ...
Zepbound lawsuit claims center on allegations that the drug may be linked to serious adverse health outcomes

Concurrent colonoscopy was found to reduce GRC risk among GLP-1 RA users (OR 0.27

(PubMed)

Despite eating healthy and working out, lasting weight loss